as 11-13-2025 3:40pm EST
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
| Founded: | 2022 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 41.7B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 8.4M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.23 | EPS Growth: | 41.64 |
| 52 Week Low/High: | $8.71 - $11.42 | Next Earning Date: | 07-31-2025 |
| Revenue: | $15,096,588,575 | Revenue Growth: | -2.12% |
| Revenue Growth (this year): | 1.41% | Revenue Growth (next year): | 4.52% |
HLN Breaking Stock News: Dive into HLN Ticker-Specific Updates for Smart Investing
Insider Monkey
5 days ago
Morningstar Research
15 days ago
MT Newswires
15 days ago
Insider Monkey
24 days ago
Pharma Voice
a month ago
Reuters Videos
2 months ago
Associated Press Finance
2 months ago
Business Wire
2 months ago
The information presented on this page, "HLN Haleon plc (Each representing two) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.